jCyte Developing Cell-based RP Treatment at Ophthalmology Innovation Summit @ AAO

  Рет қаралды 15,253

OIS: Ophthalmology Innovation Source

OIS: Ophthalmology Innovation Source

Күн бұрын

Пікірлер: 46
@scratcher9117
@scratcher9117 4 жыл бұрын
Hi...Can you please update us on the work in progress?
@lilmissunshine83
@lilmissunshine83 6 жыл бұрын
This is fantastic news! I've been following this specific trial for years.
@demoeverythingsport4161
@demoeverythingsport4161 4 жыл бұрын
Can this for glaucoma patient
@evaazzi7160
@evaazzi7160 4 жыл бұрын
I been going to doctor hos visually impairment for my son since he was born they he is 29 years old he can't see nothing in the right eye little vision in the left please let me know if you could bring his vision back please 🙏 and God bless you thank you God bless you 🙏
@denaswords3571
@denaswords3571 4 жыл бұрын
I have retinitis pigmentosa and was diagnosed with it at age 16 in 22 now now .. where do I go about the trial ??
@rayadeel150
@rayadeel150 3 жыл бұрын
Some segments in the video are stamped not adjacent to each other
@yeshwanthreddy268
@yeshwanthreddy268 3 жыл бұрын
Hello when can I expect the medicine for general public can you tell me some date of
@crazykatedits
@crazykatedits 3 жыл бұрын
May be in 2024 or 2025
@dharabts1904
@dharabts1904 4 ай бұрын
​@@crazykateditsnhaa we are in 2024 but still it's not there
@MujahidKhan-he5ko
@MujahidKhan-he5ko 3 жыл бұрын
8 month age baby rop stage 5 any hope for this?
@oaxacalifornioloco4404
@oaxacalifornioloco4404 6 жыл бұрын
I was diagnosed 3 years ago with RP and cataract. I had surgery to get rid of the cataract and my sight improve a little bit but I still can't see well. At night too little light and during the day too much light that is dificult to see. How can I contact you? Do you still have on going studies? Thank you.
@Ayush_1908
@Ayush_1908 5 жыл бұрын
EL OAXACALIFORNIO PROGRESISTA SARCASTICO I’m not answering on behalf of jcyte but i can answer this question..phase 2b is under trial and ongoing and is supposed to end this year.. you can go their website..jycte.com and you can volunteer for upcoming clinical trials. Hope this helps!
@jyotsnamathur1339
@jyotsnamathur1339 4 жыл бұрын
Glad to hear this news kindly tell me when the treatment will be available to the patients
@yeshwanthreddy268
@yeshwanthreddy268 3 жыл бұрын
When is the medicine available for patient
@crazykatedits
@crazykatedits 3 жыл бұрын
It's in phase 3 now and will take 3'4 years to approve by FDA after that we are able to go for it. Hope I don't lose my eyesight till then. Pray for me
@umutsaryldz6825
@umutsaryldz6825 3 жыл бұрын
@@crazykatedits How do you know ... It won't take 3-4 years
@crazykatedits
@crazykatedits 3 жыл бұрын
@@umutsaryldz6825according to my knowledge, I think it takes at least a year to take notes of how patients are feeling after treatment and is there any side effects of the treatment or not. And I think clinical trials take at least 1'2 years and Jcyte is now going in phase three and then FDA approval so may be 2'3 years 😅 and there are also other ongoing clinical trials for the same but I'm following Jcyte cell therapy you can check this website www.jcyte.com
@umutsaryldz6825
@umutsaryldz6825 3 жыл бұрын
@@crazykatedits thanks I'm going to ask something, will the 3 phases take more than 1 year? and when did phase 3 start ?
@ryangenayas8080
@ryangenayas8080 6 жыл бұрын
hi there, how can i avail this..but the problem is insufficient money to avail this treatment theres any way..im begging your help sir and maam..i need to work to support my family but i have this kind of disease..im from the philippines ..im willing to sacrifice my self to take over this kind of disease..thank you
@learnwithteachercynthiarea8898
@learnwithteachercynthiarea8898 4 жыл бұрын
please let me know how to avail this i have 3 children with rp
@accessibletechviews5406
@accessibletechviews5406 6 жыл бұрын
🙏🙏Now complete treatment is available for all kinds of RP patience 🙏🙏
@sourabhbansal7717
@sourabhbansal7717 6 жыл бұрын
Phanindra Kopparthi Your PK world please give more information were it is available
@r-ch-sahu3931
@r-ch-sahu3931 5 жыл бұрын
Phanindra Kopparthi Your PK world ,yes sir please let we know ,where this treatment is available.
@thordorm9478
@thordorm9478 6 жыл бұрын
Now I have some hope .... Thank u
@tomasvillacrez6010
@tomasvillacrez6010 2 жыл бұрын
Necesito traducción al castellano
@rajeshchoudhary9356
@rajeshchoudhary9356 6 жыл бұрын
hindi.rp retinaitasis pigmentosa pathalogy sucesesfully hindi jankare treatment india m.p.
@purushottamtiwari6186
@purushottamtiwari6186 4 жыл бұрын
राजेश जी क्या आप अपना नंबर देंगे आपसे बात करनी है प्लीज
@devagrawal4110
@devagrawal4110 3 жыл бұрын
Pls give ur contact no.
@TanaFinocan-n6j
@TanaFinocan-n6j 4 ай бұрын
Fahey Manor
A Stem Cell-Based Clinical Trial for Retinitis Pigmentosa: Henry Klassen, UC Irvine
25:21
California Institute for Regenerative Medicine
Рет қаралды 10 М.
Will Human Retinas Be Able to Regenerate?
3:43
OIS: Ophthalmology Innovation Source
Рет қаралды 10 М.
Quando eu quero Sushi (sem desperdiçar) 🍣
00:26
Los Wagners
Рет қаралды 15 МЛН
99.9% IMPOSSIBLE
00:24
STORROR
Рет қаралды 31 МЛН
LumiThera’s Novel Light-Based Treatment for Dry AMD
6:23
OIS: Ophthalmology Innovation Source
Рет қаралды 4,1 М.
Vitamin B3 is the NEW Holy Grail of Glaucoma Treatment. Here’s Why.
17:16
Understanding retinitis pigmentosa - John's story
5:41
EYE STROKE - Retinal Vein Occlusion (Causes, Symptoms, Treatment)
16:40
Doctor Eye Health
Рет қаралды 287 М.
"The truth about mobile phone and wireless radiation" -- Dr Devra Davis
1:01:30
The University of Melbourne
Рет қаралды 7 МЛН
A Stem Cell-Based Therapy for Retinitis Pigmentosa: The Patient's Perspective
6:16
California Institute for Regenerative Medicine
Рет қаралды 27 М.
Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa - Henry Klassen
10:10
University of California Television (UCTV)
Рет қаралды 21 М.
Retinitis Pigmentosa 1: Clinical
24:57
Craig Blackwell
Рет қаралды 15 М.
The Already Here Pandemic of Dry Eye
25:56
OIS: Ophthalmology Innovation Source
Рет қаралды 232